Haemophilus B Conjugate Vaccine Meningococcal Protein Conjugate

From Anvita Health Wiki

Contents 1 Indications 2 Dosage 3 Mechanism-of-action 4 More General Terms 5 References

Indications

• routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2-71 months of age

Dosage

• IM only
• 1st dose 2-14 months
• booster at 15 months or older (regardless of number of doses given < 15 months)

Mechanism-of-action

• highly purified capsular polysaccharide (polyribosylribitol phosphate or PRP) of Haemophilus influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an outer membrane protein complex (OMPC) of the B11 strain of Neisseria meningitidis serogroup B

More General Terms

• vaccine

References

1. RxList [1]

Haemophilus b Conjugate Vaccine - Meningococcal Protein Conjugate (Pedvax HIB)